HEADER ANTIBIOTIC 29-DEC-00 1HHY TITLE DEGLUCOBALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEGLUCOBALHIMYCIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: AMYCOLATOPSIS SP.; SOURCE 4 ORGANISM_TAXID: 37632 KEYWDS ANTIBIOTIC, GLYCOPEPTIDE, CELL WALL PEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR C.LEHMANN,G.BUNKOCZI,G.M.SHELDRICK,L.VERTESY REVDAT 8 29-JUL-20 1HHY 1 REMARK LINK SITE REVDAT 7 24-JUL-19 1HHY 1 REMARK REVDAT 6 10-JUL-19 1HHY 1 REMARK REVDAT 5 24-APR-19 1HHY 1 REMARK SEQRES LINK REVDAT 4 25-JUL-12 1HHY 1 REMARK HET HETNAM LINK REVDAT 4 2 1 SITE HETATM ANISOU CONECT REVDAT 3 13-JUL-11 1HHY 1 VERSN REVDAT 2 24-FEB-09 1HHY 1 VERSN REVDAT 1 05-SEP-03 1HHY 0 JRNL AUTH C.LEHMANN,G.BUNKOCZI,L.VERTESY,G.M.SHELDRICK JRNL TITL STRUCTURES OF GLYCOPEPTIDE ANTIBIOTICS WITH PEPTIDES THAT JRNL TITL 2 MODEL BACTERIAL CELL-WALL PRECURSORS JRNL REF J.MOL.BIOL. V. 318 723 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 12054818 JRNL DOI 10.1016/S0022-2836(02)00146-8 REMARK 2 REMARK 2 RESOLUTION. 0.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.122 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.121 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.139 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1127 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 22768 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.121 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.120 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.138 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1100 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 22298 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 160 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 261.13 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 156.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 1 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 2450 REMARK 3 NUMBER OF RESTRAINTS : 2978 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.021 REMARK 3 ANGLE DISTANCES (A) : 0.036 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.096 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.102 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.060 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.008 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.024 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.112 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: METHOD USED: MOEWS & KRETSINGER, REMARK 3 J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HHY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1290005733. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9076 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22973 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.890 REMARK 200 RESOLUTION RANGE LOW (A) : 30.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 7.390 REMARK 200 R MERGE (I) : 0.02980 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 62.9300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.45 REMARK 200 R MERGE FOR SHELL (I) : 0.08000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 28.95 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT METHODS REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.3M CIT, PH=7, 30% 1,2-PROPANEDIOL, REMARK 280 PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z REMARK 290 10555 -Y,-X,-Z+1/2 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.54300 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 21.54300 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.54300 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 21.54300 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 21.54300 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 21.54300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA 1.18 REMARK 350 TOTAL BURIED SURFACE AREA: 600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 2090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 1920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 24.22200 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 41.95373 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 64.62900 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -232.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 24.22200 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 41.95373 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 64.62900 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -24.22200 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 41.95373 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 64.62900 REMARK 350 BIOMT1 5 -0.500000 -0.866025 0.000000 24.22200 REMARK 350 BIOMT2 5 0.866025 -0.500000 0.000000 41.95373 REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 6 0.500000 0.866025 0.000000 -24.22200 REMARK 350 BIOMT2 6 0.866025 -0.500000 0.000000 41.95373 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 64.62900 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 NA NA B1002 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2005 LIES ON A SPECIAL POSITION. REMARK 375 HOH B2010 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 BALHIMYCIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS REMARK 400 A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS REMARK 400 FURTHER GLYCOSYLATED BY TWO MONOSACCHARIDES: A D-GLUCOSE REMARK 400 AND A 4-OXO-VANCOSAMINE. REMARK 400 HERE, DEGLUCOBALHIMYCIN IS REPRESENTED GROUPING TOGETHER THE REMARK 400 SEQUENCE (SEQRES) AND ONE LIGAND (HET) DVC. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DEGLUCOBALHIMYCIN REMARK 400 CHAIN: A, B REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7 REMARK 400 COMPONENT_2: SUGAR RESIDUES 9 REMARK 400 DESCRIPTION: DEGLUCOBALHIMYCIN LACKS THE D-GLUCOSE REMARK 400 COMPONENT OF BALHIMYCIN CONSISTING OF THE REMARK 400 TRICYCLIC HEPTAPEPTIDE AND 4-OXO-VANCOSAMINE REMARK 400 ONLY LINKED TO RESIDUE 6. REMARK 400 REMARK 400 THE DEGLUCOBALHIMYCIN IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC, REMARK 400 ANTIMICROBIAL CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DEGLUCOBALHIMYCIN REMARK 400 CHAIN: A, B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE DVC REMARK 400 DESCRIPTION: DEGLUCOBALHIMYCIN LACKS THE D-GLUCOSE COMPONENT OF REMARK 400 BALHIMYCIN CONSISTING OF THE TRICYCLIC HEPTAPEPTIDE REMARK 400 AND (2R,4S,6S)-4-AZANYL-4,6-DIMETHYL-OXANE-2,5,5- REMARK 400 TRIOL ONLY LINKED TO RESIDUE 6. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MLU A 1 CA - C - N ANGL. DEV. = -16.7 DEGREES REMARK 500 MLU A 1 O - C - N ANGL. DEV. = 15.6 DEGREES REMARK 500 OMZ A 2 C - N - CA ANGL. DEV. = -24.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A1001 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MLU A 1 N REMARK 620 2 HOH A2002 O 27.2 REMARK 620 3 HOH A2022 O 97.2 112.3 REMARK 620 4 HOH A2023 O 77.1 95.5 103.7 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B1002 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 PGO B1001 O2 REMARK 620 2 PGO B1001 O1 98.1 REMARK 620 3 PGO B1001 O1 159.5 92.0 REMARK 620 4 PGO B1001 O2 102.2 69.9 98.1 REMARK 620 5 PGO B1001 O2 102.2 159.5 69.9 102.2 REMARK 620 6 PGO B1001 O1 69.9 92.0 92.0 159.5 98.1 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GO6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BALHIMYCIN COMPLEXED WITH THE PEPTIDE LYS-DAL- REMARK 900 DAL REMARK 900 RELATED ID: 1HHU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BALHIMYCIN COMPLEXED WITH DAL-DAL REMARK 900 RELATED ID: 1HHZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DEGLUCOBALHIMYCIN COPMLEXED WITH CELL WALL REMARK 900 PENTAPEPTIDE DBREF 1HHY A 1 7 NOR NOR00707 NOR00707 1 7 DBREF 1HHY B 1 7 NOR NOR00707 NOR00707 1 7 SEQRES 1 A 7 MLU OMZ ASN GHP GHP OMY 3FG SEQRES 1 B 7 MLU OMZ ASN GHP GHP OMY 3FG MODRES 1HHY OMY A 6 TYR MODRES 1HHY OMY B 6 TYR HET MLU A 1 18 HET OMZ A 2 15 HET GHP A 4 11 HET GHP A 5 11 HET OMY A 6 14 HET 3FG A 7 13 HET MLU B 1 9 HET OMZ B 2 14 HET GHP B 4 11 HET GHP B 5 11 HET OMY B 6 14 HET 3FG B 7 13 HET DVC A 9 11 HET DAL A 11 5 HET DAL A 12 6 HET NA A1001 1 HET DVC B 9 11 HET DAL B 11 5 HET DAL B 12 6 HET PGO B1001 5 HET NA B1002 1 HETNAM MLU N-METHYL-D-LEUCINE HETNAM OMZ (BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM OMY (BETAR)-3-CHLORO-BETA-HYDROXY-L-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM DVC (2R,4S,6S)-4-AZANYL-4,6-DIMETHYL-OXANE-2,5,5-TRIOL HETNAM DAL D-ALANINE HETNAM NA SODIUM ION HETNAM PGO S-1,2-PROPANEDIOL FORMUL 1 MLU 2(C7 H15 N O2) FORMUL 1 OMZ 2(C9 H10 CL N O4) FORMUL 1 GHP 4(C8 H9 N O3) FORMUL 1 OMY 2(C9 H10 CL N O4) FORMUL 1 3FG 2(C8 H9 N O4) FORMUL 3 DVC 2(C7 H15 N O4) FORMUL 4 DAL 4(C3 H7 N O2) FORMUL 6 NA 2(NA 1+) FORMUL 10 PGO C3 H8 O2 FORMUL 12 HOH *53(H2 O) LINK C AMLU A 1 N AOMZ A 2 1555 1555 1.41 LINK C BMLU A 1 N BOMZ A 2 1555 1555 1.45 LINK C OMZ A 2 N ASN A 3 1555 1555 1.24 LINK OH OMZ A 2 C3 GHP A 4 1555 1555 1.40 LINK C ASN A 3 N GHP A 4 1555 1555 1.32 LINK C GHP A 4 N GHP A 5 1555 1555 1.35 LINK C5 GHP A 4 OCZ OMY A 6 1555 1555 1.39 LINK C GHP A 5 N OMY A 6 1555 1555 1.31 LINK C5 GHP A 5 CG1 3FG A 7 1555 1555 1.47 LINK C OMY A 6 N 3FG A 7 1555 1555 1.34 LINK ODE OMY A 6 C1 DVC A 9 1555 1555 1.41 LINK C DAL A 11 N DAL A 12 1555 1555 1.36 LINK C MLU B 1 N OMZ B 2 1555 1555 1.36 LINK C OMZ B 2 N ASN B 3 1555 1555 1.32 LINK OH OMZ B 2 C3 GHP B 4 1555 1555 1.39 LINK C ASN B 3 N GHP B 4 1555 1555 1.33 LINK C GHP B 4 N GHP B 5 1555 1555 1.34 LINK C5 GHP B 4 OCZ OMY B 6 1555 1555 1.39 LINK C GHP B 5 N OMY B 6 1555 1555 1.33 LINK C5 GHP B 5 CG1 3FG B 7 1555 1555 1.47 LINK C OMY B 6 N 3FG B 7 1555 1555 1.35 LINK ODE OMY B 6 C1 DVC B 9 1555 1555 1.40 LINK C DAL B 11 N DAL B 12 1555 1555 1.30 LINK N AMLU A 1 NA NA A1001 1555 1555 3.13 LINK NA NA A1001 O HOH A2002 1555 1555 3.17 LINK NA NA A1001 O HOH A2022 1555 10666 3.11 LINK NA NA A1001 O HOH A2023 1555 1555 3.18 LINK O2 PGO B1001 NA NA B1002 3565 1555 2.38 LINK O1 PGO B1001 NA NA B1002 1555 1555 2.47 LINK O1 PGO B1001 NA NA B1002 2665 1555 2.47 LINK O2 PGO B1001 NA NA B1002 1555 1555 2.38 LINK O2 PGO B1001 NA NA B1002 2665 1555 2.38 LINK O1 PGO B1001 NA NA B1002 3565 1555 2.47 CISPEP 1 GHP A 5 OMY A 6 0 -1.10 CISPEP 2 GHP B 5 OMY B 6 0 2.90 CRYST1 48.444 48.444 43.086 90.00 90.00 120.00 P 63 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020642 0.011918 0.000000 0.00000 SCALE2 0.000000 0.023836 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023209 0.00000 MTRIX1 1 0.309860 -0.758630 -0.573120 37.06617 1 MTRIX2 1 -0.760620 -0.559470 0.329320 35.15608 1 MTRIX3 1 -0.570470 0.333880 -0.750390 37.59990 1 HETATM 1 N AMLU A 1 12.868 28.136 33.976 0.60 7.24 N ANISOU 1 N AMLU A 1 801 954 995 164 -100 -255 N HETATM 2 N BMLU A 1 13.717 29.521 33.558 0.40 14.28 N ANISOU 2 N BMLU A 1 2119 1951 1353 -143 -431 -445 N HETATM 3 CN AMLU A 1 11.755 29.159 34.168 0.60 8.84 C ANISOU 3 CN AMLU A 1 1226 1146 988 443 106 -37 C HETATM 4 CN BMLU A 1 12.600 30.647 33.539 0.40 19.91 C ANISOU 4 CN BMLU A 1 4510 2045 1009 -88 -172 -72 C HETATM 5 CA AMLU A 1 12.967 27.572 32.597 0.60 6.86 C ANISOU 5 CA AMLU A 1 843 867 897 181 -109 -143 C HETATM 6 CA BMLU A 1 13.738 28.610 32.370 0.40 11.34 C ANISOU 6 CA BMLU A 1 1211 1942 1155 -125 -260 -292 C HETATM 7 C AMLU A 1 13.040 28.748 31.607 0.60 7.59 C ANISOU 7 C AMLU A 1 703 987 1194 38 64 -54 C HETATM 8 C BMLU A 1 13.510 29.590 31.204 0.40 9.78 C ANISOU 8 C BMLU A 1 886 1478 1351 -77 -230 -406 C HETATM 9 O AMLU A 1 14.001 29.484 31.706 0.60 9.35 O ANISOU 9 O AMLU A 1 958 1220 1375 -132 -463 -54 O HETATM 10 O BMLU A 1 14.325 30.489 30.958 0.40 12.86 O ANISOU 10 O BMLU A 1 1753 1633 1501 -414 -27 -498 O HETATM 11 CB AMLU A 1 14.105 26.585 32.558 0.60 8.08 C ANISOU 11 CB AMLU A 1 919 1276 874 383 -127 -198 C HETATM 12 CB BMLU A 1 14.925 27.790 32.191 0.40 11.33 C ANISOU 12 CB BMLU A 1 1035 1870 1399 -56 -420 -158 C HETATM 13 CG AMLU A 1 14.082 25.652 31.312 0.60 8.67 C ANISOU 13 CG AMLU A 1 655 1429 1208 335 -273 -321 C HETATM 14 CG BMLU A 1 14.983 26.873 30.922 0.40 10.59 C ANISOU 14 CG BMLU A 1 1237 1335 1451 438 -493 -123 C HETATM 15 CD1AMLU A 1 14.882 24.408 31.619 0.60 10.00 C ANISOU 15 CD1AMLU A 1 718 1313 1767 203 32 -92 C HETATM 16 CD1BMLU A 1 14.301 25.520 31.063 0.40 19.39 C ANISOU 16 CD1BMLU A 1 2899 1921 2549 -590 -42 -191 C HETATM 17 CD2AMLU A 1 14.624 26.321 30.162 0.60 10.89 C ANISOU 17 CD2AMLU A 1 1227 1849 1063 574 -65 -174 C HETATM 18 CD2BMLU A 1 16.367 26.666 30.662 0.40 16.18 C ANISOU 18 CD2BMLU A 1 1750 2047 2349 907 529 590 C HETATM 19 N AOMZ A 2 11.998 28.823 30.660 0.60 9.01 N ANISOU 19 N AOMZ A 2 1025 1243 1155 -22 -449 -142 N HETATM 20 N BOMZ A 2 12.307 29.032 30.620 0.40 8.22 N ANISOU 20 N BOMZ A 2 489 1536 1097 440 -275 -611 N HETATM 21 CA OMZ A 2 12.159 29.951 29.604 1.00 9.43 C ANISOU 21 CA OMZ A 2 962 1243 1379 133 -29 -479 C HETATM 22 C OMZ A 2 12.023 29.401 28.188 1.00 7.88 C ANISOU 22 C OMZ A 2 742 1018 1235 90 -41 -260 C HETATM 23 O OMZ A 2 12.151 30.256 27.252 1.00 8.92 O ANISOU 23 O OMZ A 2 1072 837 1478 15 -36 -450 O HETATM 24 CB OMZ A 2 11.054 31.058 29.821 1.00 10.07 C ANISOU 24 CB OMZ A 2 1101 1237 1488 229 -110 -687 C HETATM 25 OC OMZ A 2 11.201 31.479 31.215 1.00 12.52 O ANISOU 25 OC OMZ A 2 1306 1915 1535 155 -190 -858 O HETATM 26 CG OMZ A 2 9.636 30.482 29.633 1.00 8.67 C ANISOU 26 CG OMZ A 2 940 1178 1177 315 -66 -440 C HETATM 27 CD1 OMZ A 2 9.051 30.742 28.326 1.00 8.33 C ANISOU 27 CD1 OMZ A 2 978 1085 1101 242 53 -249 C HETATM 28 CD2 OMZ A 2 9.003 29.716 30.563 1.00 8.83 C ANISOU 28 CD2 OMZ A 2 1088 1355 913 437 -82 -275 C HETATM 29 CE1 OMZ A 2 7.859 30.156 28.076 1.00 7.57 C ANISOU 29 CE1 OMZ A 2 747 1063 1067 283 -42 -164 C HETATM 30 CL OMZ A 2 7.127 30.389 26.489 1.00 8.08 CL ANISOU 30 CL OMZ A 2 930 1057 1082 149 -50 -57 CL HETATM 31 CE2 OMZ A 2 7.789 29.107 30.271 1.00 9.06 C ANISOU 31 CE2 OMZ A 2 1098 1164 1181 428 21 -142 C HETATM 32 CZ OMZ A 2 7.250 29.328 28.968 1.00 7.90 C ANISOU 32 CZ OMZ A 2 842 1105 1054 440 76 -85 C HETATM 33 OH OMZ A 2 6.112 28.647 28.684 1.00 7.94 O ANISOU 33 OH OMZ A 2 811 1049 1157 289 158 -100 O